Drupal.behaviors.print = function(context) {window.print();window.close();}>
Complete Genomics Sees Future in Cancer Genome Sequencing; Plans New Cancer-Specific Product
March 16, 2011
Complete Genomics Sees Future in Cancer Genome Sequencing; Plans New Cancer-Specific Product
"In the long run, we plan to be
the
tumor sequencing company," said CEO Cliff Reid.
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Complete Views Inova Contract as First of Many Healthcare Deals, Expects CLIA Certification in 2012
August 9, 2011 / Clinical Sequencing News
Complete Genomics Signs Two Contracts Worth $14M as Falling Prices Impact Q2 Revenues
August 9, 2011 / In Sequence
Complete Genomics To Award Free Sequencing Under Cancer Grant Program
July 6, 2011 / Clinical Sequencing News
Erasmus Orders 250 Genomes from Complete Genomics to Study Cancer, Congenital Malformations
May 24, 2011 / Clinical Sequencing News
Increasing Investment in Next-Gen Sequencing, Genomic Health Takes $2.8M Stake in Two Startups
May 4, 2011 / Clinical Sequencing News